Halozyme Appoints David Ramsay as Interim Chief Financial Officer
Go back to Halozyme Appoints David Ramsay as Interim Chief Financial Officer| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 110.19 -0.57 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.76 | 52 Week High | $18.39 | |||
| Open | $109.91 | 52 Week Low | $6.96 | |||
| Day High | $111.15 | P/E | N/A | |||
| Day Low | $109.00 | EPS | $-0.58 | |||
| Volume | 1,010,598 | |||||
